Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-15

FDA Approved: CLOPIDOGREL BISULFATE — Original Application (RADHA PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA approved the original ANDA for clopidogrel bisulfate, a generic antiplatelet agent, expanding access to a therapy that reduces vascular events in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

ORIG AP for CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE)